Genetic engineering used to be rather clunky, the New Scientist says, but recent advances in genome editing using the CRISPR-Cas9 system are speeding things up. Instead of relying on artificial proteins, the CRISPR-Cas9 system is RNA-based.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.
Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.
Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.